In CAR T-cell therapy for diffuse large B-cell lymphoma, distinct archetypes could guide personalized treatment decisions.

A study identifies three patient subgroups in large B-cell lymphoma, revealing distinct responses to CD19 CAR T cell therapy ...

Analysis revealed that patients with T-cell exhausted archetype tumors had significantly higher rates of progressive disease ...

Some of the most harmful genetic changes in cancer are also the hardest to see. These structural alterations, deep within a ...

Inside your body, countless processes are happening every second to keep you alive. Among them is a little-known but powerful ...

In the largest study of its kind, researchers from The University of Texas MD Anderson Cancer Center identified three ...

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

Cancer research reveals blood tests can detect tumor-derived mutations years before diagnosis. Johns Hopkins scientists ...

This well-tolerated investigational combination therapy avoids traditional chemotherapy and may be suitable for outpatient community care These data demonstrate Roche's commitment to providing options ...

Water makes up around 60% of the human body. More than half of this water sloshes around inside the cells that make up organs ...

Glioblastoma has been deadly and hard to treat, but researchers say they’ve made progress with bivalent CAR T-cell therapy ...